EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gynecologic surgery for benign disease: Preserving reproductive potential

Togas Tulandi iD, Edgar Mocanu, Nikhil Purandare, Scott M Nelson, Eytan R Barnea, Ruth Dolmo Carluccio, Elif Goknur Topcu, Dov Feldberg, FIGO Committee on Reproductive Endocrinology and Infertility

International Journal of Gynecology & Obstetrics · 2025-12 · 171 (3) · 1022-1028

DOI: 10.1002/ijgo.70546 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 24.09.2025. Verfasst von Togas Tulandi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Fertility Preservation, Gynecologic Surgical Procedures, Genital Diseases, Female. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preserving fertility is essential when managing benign gynecologic disorders in reproductive‐aged women. Surgical interventions can impact future fertility, therefore requiring an evidence‐based, individualized approach. The FIGO Committee on Reproductive Endocrinology and Infertility reviewed current literature to develop recommendations for fertility‐sparing surgical management. Effective treatment must balance disease control with fertility preservation. Evidence supports refined surgical techniques and alternative methods that minimize reproductive harm. In pregnancy loss management, medical treatment is preferred; however, if surgery is needed, hysteroscopic evacuation is safer than sharp curettage, reducing the risk of intrauterine adhesions. Similarly for other operative hysteroscopic procedures or abdominal procedures, including myomectomy, the use of an adhesion‐reducing substance is recommended. During abdominal myomectomy, only symptomatic or fertility‐impairing fibroids should be removed, as excessive resection may reduce pregnancy chances. In endometrioma surgery, preserving ovarian tissue is crucial by minimizing stripping of the pseudocapsule, or using sclerotherapy may help. Oocyte cryopreservation should be discussed when recurrence or reduced ovarian reserve is a concern. Hydrosalpinx often requires salpingectomy to enhance in vitro fertilization outcomes, but surgeons should protect ovarian blood flow by minimizing thermal injury. For adenomyosis, medical management is preferred due to the risks associated with surgical techniques like the triple‐flap procedure. In polycystic ovary syndrome, laparoscopic ovarian drilling is discouraged; ovulation induction with letrozole or gonadotropins is safer and effective. In summary, fertility‐sparing treatment demands personalized, evidence‐based strategies that prioritize reproductive potential while managing disease. As reproductive goals evolve, continued refinement of these approaches remains vital to women's health care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationGynecologic Surgical ProceduresGenital Diseases, FemaleHumansFemalePregnancyInfertility, FemaleUterine MyomectomyLeiomyoma

Stichwörter der Autor:innen

FIGObenign gynecologic surgeryfertility‐sparing surgeryinfertilityreproductive functionreproductive surgery

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.
  • Rotunda Hospital, Dublin, Ireland.
  • Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Department of Obstetrics and Gynaecology, Galway University Hospital, Galway, Ireland.
  • School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
  • University of Miami Miller School of Medicine, New York, New York, USA.

ORCID-Profile: Togas Tulandi

Zitieren

APA

Tulandi, T., Mocanu, E., Purandare, N., Nelson, S. M., Barnea, E. R., Dolmo Carluccio, R., Topcu, E. G., Feldberg, D., & FIGO Committee on Reproductive Endocrinology and Infertility (2025). Gynecologic surgery for benign disease: Preserving reproductive potential. International Journal of Gynecology & Obstetrics, 171(3), 1022-1028. https://doi.org/10.1002/ijgo.70546

Vancouver

Tulandi T, Mocanu E, Purandare N, Nelson SM, Barnea ER, Dolmo Carluccio R, et al. Gynecologic surgery for benign disease: Preserving reproductive potential. International Journal of Gynecology & Obstetrics. 2025;171(3):1022-1028. doi:10.1002/ijgo.70546

BibTeX
@article{Tulandi2025,
  author = {Tulandi, Togas and Mocanu, Edgar and Purandare, Nikhil and Nelson, Scott M and Barnea, Eytan R and Dolmo Carluccio, Ruth and Topcu, Elif Goknur and Feldberg, Dov and FIGO Committee on Reproductive Endocrinology and Infertility, FIGO Committee on Reproductive Endocrinology and Infertility},
  title = {Gynecologic surgery for benign disease: Preserving reproductive potential},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  volume = {171},
  number = {3},
  pages = {1022--1028},
  doi = {10.1002/ijgo.70546}
}
Kostenlos starten →